Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 12 June 1992:
Vol. 256. no. 5063, pp. 1550 - 1552
DOI: 10.1126/science.1317968

Articles

Science, Vol 256, Issue 5063, 1550-1552
Copyright © 1992 by American Association for the Advancement of Science


articles

In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors

KW Culver, Z Ram, S Wallbridge, H Ishii, EH Oldfield, and RM Blaese

Cellular Immunology Section, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.

Direct in situ introduction of exogenous genes into proliferating tumors could provide an effective therapeutic approach for treatment of localized tumors. Rats with a cerebral glioma were given an intratumoral stereotaxic injection of murine fibroblasts that were producing a retroviral vector in which the herpes simplex thymidine kinase (HS-tk) gene had been inserted. After 5 days during which the HS-tk retroviral vectors that were produced in situ transduced the neighboring proliferating glioma cells, the rats were treated with the anti-herpes drug ganciclovir. Gliomas in the ganciclovir- and vector-treated rats regressed completely both macroscopically and microscopically. This technique exploits what was previously considered to be a disadvantage of retroviral vectors--that is, their inability to transfer genes into nondividing cells. Instead, this feature of retroviruses is used to target gene delivery to dividing tumor cells and to spare nondividing neural tissue.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
A heterotypic bystander effect for tumor cell killing after adeno-associated virus/phage-mediated, vascular-targeted suicide gene transfer.
M. Trepel, C. A. Stoneham, H. Eleftherohorinou, N. D. Mazarakis, R. Pasqualini, W. Arap, and A. Hajitou (2009)
Mol. Cancer Ther. 8, 2383-2391
   Abstract »    Full Text »    PDF »
Directed evolution of an orthogonal nucleoside analog kinase via fluorescence-activated cell sorting.
L. Liu, Y. Li, D. Liotta, and S. Lutz (2009)
Nucleic Acids Res. 37, 4472-4481
   Abstract »    Full Text »    PDF »
Titration of Variant HSV1-tk Gene Expression to Determine the Sensitivity of 18F-FHBG PET Imaging in a Prostate Tumor.
M. Johnson, B. D.W. Karanikolas, S. J. Priceman, R. Powell, M. E. Black, H.-M. Wu, J. Czernin, S.-C. Huang, and L. Wu (2009)
J. Nucl. Med. 50, 757-764
   Abstract »    Full Text »    PDF »
Normal Brain Cells Contribute to the Bystander Effect in Suicide Gene Therapy of Malignant Glioma.
H. Miletic, Y. H. Fischer, T. Giroglou, M. A. Rueger, A. Winkeler, H. Li, U. Himmelreich, W. Stenzel, A. H. Jacobs, and D. von Laer (2007)
Clin. Cancer Res. 13, 6761-6768
   Abstract »    Full Text »    PDF »
Cationic Albumin-Conjugated Pegylated Nanoparticles Allow Gene Delivery into Brain Tumors via Intravenous Administration.
W. Lu, Q. Sun, J. Wan, Z. She, and X.-G. Jiang (2006)
Cancer Res. 66, 11878-11887
   Abstract »    Full Text »    PDF »
Molecular Imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for Monitoring Herpes Simplex Virus Type 1 Thymidine Kinase and Ganciclovir Prodrug Activation Gene Therapy of Cancer.
H.-E. Wang, H.-M. Yu, R.-S. Liu, M. Lin, J. G. Gelovani, J.-J. Hwang, H.-J. Wei, and W.-P. Deng (2006)
J. Nucl. Med. 47, 1161-1171
   Abstract »    Full Text »    PDF »
Hydroxyurea Induces Bystander Cytotoxicity in Cocultures of Herpes Simplex Virus Thymidine Kinase-Expressing and Nonexpressing HeLa Cells Incubated with Ganciclovir..
B. G. Gentry, P. D. Boucher, and D. S. Shewach (2006)
Cancer Res. 66, 3845-3851
   Abstract »    Full Text »    PDF »
Therapeutic protein transduction of mammalian cells and mice by nucleic acid-free lentiviral nanoparticles.
N. Link, C. Aubel, J. M. Kelm, R. R. Marty, D. Greber, V. Djonov, J. Bourhis, W. Weber, and M. Fussenegger (2006)
Nucleic Acids Res. 34, e16
   Abstract »    Full Text »    PDF »
Long-term Follow-up of Patients with Malignant Pleural Mesothelioma Receiving High-Dose Adenovirus Herpes Simplex Thymidine Kinase/Ganciclovir Suicide Gene Therapy.
D. H. Sterman, A. Recio, A. Vachani, J. Sun, L. Cheung, P. DeLong, K. M. Amin, L. A. Litzky, J. M. Wilson, L. R. Kaiser, et al. (2005)
Clin. Cancer Res. 11, 7444-7453
   Abstract »    Full Text »    PDF »
Gonadotropin-releasing hormone receptor-targeted gene therapy of gynecologic cancers.
C. Grundker, A. Huschmand Nia, and G. Emons (2005)
Mol. Cancer Ther. 4, 225-232
   Abstract »    Full Text »    PDF »
Inhibitory effect of recombinant adenovirus carrying melittin gene on hepatocellular carcinoma.
C.-Q. Ling, B. Li, C. Zhang, D.-Z. Zhu, X.-Q. Huang, W. Gu, and S.-X. Li (2005)
Ann. Onc. 16, 109-115
   Abstract »    Full Text »    PDF »
Efficacy and Safety Evaluation of Human Reovirus Type 3 in Immunocompetent Animals: Racine and Nonhuman Primates.
W. Q. Yang, X. Lun, C. A. Palmer, M. E. Wilcox, H. Muzik, Z. Q. Shi, R. Dyck, M. Coffey, B. Thompson, M. Hamilton, et al. (2004)
Clin. Cancer Res. 10, 8561-8576
   Abstract »    Full Text »    PDF »
Synthesis and Evaluation of 2'-Deoxy-2'-18F-Fluoro-5-Fluoro-1-{beta}-D-Arabinofuranosyluracil as a Potential PET Imaging Agent for Suicide Gene Expression.
M. M. Alauddin, A. Shahinian, R. Park, M. Tohme, J. D. Fissekis, and P. S. Conti (2004)
J. Nucl. Med. 45, 2063-2069
   Abstract »    Full Text »    PDF »
Potent Tumor-Specific Immunity Induced by an In vivo Heat Shock Protein-Suicide Gene-Based Tumor Vaccine.
W. Ren, R. Strube, X. Zhang, S.-Y. Chen, and X. F. Huang (2004)
Cancer Res. 64, 6645-6651
   Abstract »    Full Text »    PDF »
Structural Basis for Substrate Specificity of Escherichia coli Purine Nucleoside Phosphorylase.
E. M. Bennett, C. Li, P. W. Allan, W. B. Parker, and S. E. Ealick (2003)
J. Biol. Chem. 278, 47110-47118
   Abstract »    Full Text »    PDF »
Lipid-mediated Protein Delivery of Suicide Nucleoside Kinases.
X. Zheng, M. Lundberg, A. Karlsson, and M. Johansson (2003)
Cancer Res. 63, 6909-6913
   Abstract »    Full Text »    PDF »
A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma.
M. Westphal, D. C. Hilt, E. Bortey, P. Delavault, R. Olivares, P. C. Warnke, I. R. Whittle, J. Jaaskelainen, and Z. Ram (2003)
Neuro-oncol 5, 79-88
   Abstract »    PDF »
Expression of MRP4 Confers Resistance to Ganciclovir and Compromises Bystander Cell Killing.
M. Adachi, J. Sampath, L.-b. Lan, D. Sun, P. Hargrove, R. Flatley, A. Tatum, M. Z. Edwards, M. Wezeman, L. Matherly, et al. (2002)
J. Biol. Chem. 277, 38998-39004
   Abstract »    Full Text »    PDF »
Stable micro-dystrophin gene transfer using an integrating adeno-retroviral hybrid vector ameliorates the dystrophic pathology in mdx mouse muscle.
M. L. Roberts, D. J. Wells, I. R. Graham, S. A. Fabb, V. J. Hill, G. Duisit, K. Yuasa, S.'i. Takeda, F.-L. Cosset, and G. Dickson (2002)
Hum. Mol. Genet. 11, 1719-1730
   Abstract »    Full Text »    PDF »
Oncoretrovirus and Lentivirus Vectors Pseudotyped with Lymphocytic Choriomeningitis Virus Glycoprotein: Generation, Concentration, and Broad Host Range.
W. R. Beyer, M. Westphal, W. Ostertag, and D. von Laer (2002)
J. Virol. 76, 1488-1495
   Abstract »    Full Text »    PDF »
Influence of transfection with connexin 26 gene on malignant potential of human hepatoma cells.
A. Muramatsu, M. Iwai, T. Morikawa, S. Tanaka, T. Mori, Y. Harada, and T. Okanoue (2002)
Carcinogenesis 23, 351-358
   Abstract »    Full Text »    PDF »
Treatment of Malignant Gliomas with a Replicating Adenoviral Vector Expressing Herpes Simplex Virus-Thymidine Kinase.
D. Nanda, R. Vogels, M. Havenga, C. J. Avezaat, A. Bout, and P. S. Smitt (2001)
Cancer Res. 61, 8743-8750
   Abstract »    Full Text »    PDF »
Imaging Techniques for Gene Therapy: SPECT, PET, and MRI.
U. Haberkorn and A. Altmann (2001)
Journal of Pharmacy Practice 14, 383-396
   Abstract »    PDF »
Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma.
A Ly, H T Duc, M Kalamarides, L A Trojan, Y Pan, A Shevelev, J-C Francois, T Noel, A Kane, D Henin, et al. (2001)
Mol. Pathol. 54, 230-239
   Abstract »    Full Text »    PDF »
Bystander Effects of Cancer Cell Lines Transduced with the Multisubstrate Deoxyribonucleoside Kinase of Drosophila melanogaster and Synergistic Enhancement by Hydroxyurea.
X. Zheng, M. Johansson, and A. Karlsson (2001)
Mol. Pharmacol. 60, 262-266
   Abstract »    Full Text »    PDF »
Reovirus as an Oncolytic Agent Against Experimental Human Malignant Gliomas.
M. E. Wilcox, W. Yang, D. Senger, N. B. Rewcastle, D. G. Morris, P. M. A. Brasher, Z. Q. Shi, R. N. Johnston, S. Nishikawa, P. W. K. Lee, et al. (2001)
J Natl Cancer Inst 93, 903-912
   Abstract »    Full Text »    PDF »
Engineering of Macrophages to Produce IFN-{{gamma}} in Response to Hypoxia.
L. Carta, S. Pastorino, G. Melillo, M. C. Bosco, S. Massazza, and L. Varesio (2001)
J. Immunol. 166, 5374-5380
   Abstract »    Full Text »    PDF »
Selective Abolishment of Pyrimidine Nucleoside Kinase Activity of Herpes Simplex Virus Type 1 Thymidine Kinase by Mutation of Alanine-167 to Tyrosine.
B. Degrève, R. Esnouf, E. De Clercq, and J. Balzarini (2001)
Mol. Pharmacol. 58, 1326-1332
   Abstract »    Full Text »
Potential of gene therapy for brain tumors.
P. Y.P. Lam and X. O. Breakefield (2001)
Hum. Mol. Genet. 10, 777-787
   Abstract »    Full Text »    PDF »
Positron Emission Tomography-based Imaging of Transgene Expression Mediated by Replication-conditional, Oncolytic Herpes Simplex Virus Type 1 Mutant Vectors in Vivo.
A. Jacobs, J. G. Tjuvajev, M. Dubrovin, T. Akhurst, J. Balatoni, B. Beattie, R. Joshi, R. Finn, S. M. Larson, U. Herrlinger, et al. (2001)
Cancer Res. 61, 2983-2995
   Abstract »    Full Text »
Antiviral Guanosine Analogs as Substrates for Deoxyguanosine Kinase: Implications for Chemotherapy.
A. H. Sjöberg, L. Wang, and S. Eriksson (2001)
Antimicrob. Agents Chemother. 45, 739-742
   Abstract »    Full Text »
Mutation of Gln125 to Asn Selectively Abolishes the Thymidylate Kinase Activity of Herpes Simplex Virus Type 1 Thymidine Kinase.
B. Degrève, R. Esnouf, E. De Clercq, and J. Balzarini (2001)
Mol. Pharmacol. 59, 285-293
   Abstract »    Full Text »
A TVA-Single-Chain Antibody Fusion Protein Mediates Specific Targeting of a Subgroup A Avian Leukosis Virus Vector to Cells Expressing a Tumor-Specific Form of Epidermal Growth Factor Receptor.
S. Snitkovsky, T. M. J. Niederman, B. S. Carter, R. C. Mulligan, and J. A. T. Young (2000)
J. Virol. 74, 9540-9545
   Abstract »    Full Text »
Combined suicide and cytokine gene therapy for peritoneal carcinomatosis.
C Lechanteur, P Delvenne, F Princen, M Lopez, G Fillet, J Gielen, M-P Merville, and V Bours (2000)
Gut 47, 343-348
   Abstract »    Full Text »    PDF »
Thrombasthenic mice generated by replacement of the integrin alpha IIb gene: demonstration that transcriptional activation of this megakaryocytic locus precedes lineage commitment.
D. T.-L. Roux, V. Roullot, C. Poujol, T. Kortulewski, P. Nurden, and G. Marguerie (2000)
Blood 96, 1399-1408
   Abstract »    Full Text »    PDF »
Bystander Effect in Herpes Simplex Virus-Thymidine Kinase/Ganciclovir Cancer Gene Therapy: Role of Gap-junctional Intercellular Communication1.
M. Mesnil and H. Yamasaki (2000)
Cancer Res. 60, 3989-3999
   Abstract »    Full Text »
Impact of genomics on drug discovery and clinical medicine.
G. Emilien, M. Ponchon, C. Caldas, O. Isacson, and J.-M. Maloteaux (2000)
QJM 93, 391-423
   Abstract »    Full Text »    PDF »
Glioblastoma multiforme: The terminator.
E. C. Holland (2000)
PNAS 97, 6242-6244
   Full Text »    PDF »
Intergeneric poliovirus recombinants for the treatment of malignant glioma.
M. Gromeier, S. Lachmann, M. R. Rosenfeld, P. H. Gutin, and E. Wimmer (2000)
PNAS 97, 6803-6808
   Abstract »    Full Text »    PDF »
Analysis of Tissue Chimerism in Nude Mouse Brain and Abdominal Xenograft Models of Human Glioblastoma Multiforme: What Does It Tell Us About the Models and About Glioblastoma Biology and Therapy?.
L. Antunes, K. S. Angioi–Duprez, S. R. Bracard, N. A. Klein–Monhoven, A. E. Le Faou, A. M. Duprez, and F. M. Plénat (2000)
J. Histochem. Cytochem. 48, 847-858
   Abstract »    Full Text »
Inhibition of Angiogenesis and Induction of Apoptosis Are Involved in E1A-mediated Bystander Effect and Tumor Suppression.
R. Shao, W. Xia, and M.-C. Hung (2000)
Cancer Res. 60, 3123-3126
   Abstract »    Full Text »
Cancer Gene Therapy by Thyroid Hormone-mediated Expression of Toxin Genes.
V. Martín, M. L. Cortés, Pablo de Felipe, A. Farsetti, N. B. Calcaterra, and M. Izquierdo (2000)
Cancer Res. 60, 3218-3224
   Abstract »    Full Text »
Transactivation of the Metallothionein Promoter in Cisplatin-Resistant Cancer Cells: a Specific Gene Therapy Strategy.
D. Vandier, V. Calvez, L. Massade, A. Gouyette, L. Mickley, T. Fojo, and O. Rixe (2000)
J Natl Cancer Inst 92, 642-647
   Abstract »    Full Text »    PDF »
Gene Transfer into Brain Parenchyma Elicits Antitumor Effects.
H. M. Fathallah-Shaykh, A. I. Kafrouni, L.-J. Zhao, G. M. Smith, and J. Forman (2000)
Cancer Res. 60, 1797-1799
   Abstract »    Full Text »
Cytogenetic genotoxicity of anti-herpes purine nucleoside analogues in CHO cells expressing the thymidine kinase gene of herpes simplex virus type 1: comparison of ganciclovir, penciclovir and aciclovir.
R. Thust, M. Tomicic, R. Klocking, P. Wutzler, and B. Kaina (2000)
Mutagenesis 15, 177-184
   Abstract »    Full Text »    PDF »
An oncolytic herpes simplex virus type 1 selectively destroys diffuse liver metastases from colon carcinoma.
S. S. YOON, H. NAKAMURA, N. M. CARROLL, B. P. BODE, E. A. CHIOCCA, and K. K. TANABE (2000)
FASEB J 14, 301-311
   Abstract »    Full Text »
Cellular Suicide Therapy of Malignant Disease.
C. J. Link, T. Seregina, A. Traynor, and R. K. Burt (2000)
Oncologist 5, 68-74
   Abstract »    Full Text »
Differential Ganciclovir-mediated Cell Killing by Glutamine 125 Mutants of Herpes Simplex Virus Type 1 Thymidine Kinase.
R. R. Drake, T. N. Wilbert, T. A. Hinds, and K. M. Gilbert (1999)
J. Biol. Chem. 274, 37186-37192
   Abstract »    Full Text »    PDF »
Single-Step Conversion of Cells to Retrovirus Vector Producers with Herpes Simplex Virus-Epstein-Barr Virus Hybrid Amplicons.
M. Sena-Esteves, Y. Saeki, S. M. Camp, E. A. Chiocca, and X. O. Breakefield (1999)
J. Virol. 73, 10426-10439
   Abstract »    Full Text »
A Cell Type-specific and Gap Junction-independent Mechanism for the Herpes Simplex Virus-1 Thymidine Kinase Gene/Ganciclovir-mediated Bystander Effect.
F. Princen, P. Robe, C. Lechanteur, M. Mesnil, J.-M. Rigo, J. Gielen, M.-P. Merville, and V. Bours (1999)
Clin. Cancer Res. 5, 3639-3644
   Abstract »    Full Text »    PDF »
X-Ray Irradiation Induces Thymidine Phosphorylase and Enhances the Efficacy of Capecitabine (Xeloda) in Human Cancer Xenografts.
N. Sawada, T. Ishikawa, F. Sekiguchi, Y. Tanaka, and H. Ishitsuka (1999)
Clin. Cancer Res. 5, 2948-2953
   Abstract »    Full Text »    PDF »
Cloning and Characterization of the Multisubstrate Deoxyribonucleoside Kinase of Drosophila melanogaster.
M. Johansson, A. R. Van Rompay, B. Degreve, J. Balzarini, and A. Karlsson (1999)
J. Biol. Chem. 274, 23814-23819
   Abstract »    Full Text »    PDF »
Herpes simplex virus thymidine kinase/ganciclovir-induced apoptosis involves ligand-independent death receptor aggregation and activation of caspases.
C. Beltinger, S. Fulda, T. Kammertoens, E. Meyer, W. Uckert, and K.-M. Debatin (1999)
PNAS 96, 8699-8704
   Abstract »    Full Text »    PDF »
Ionizing Radiation Improves Survival in Mice Bearing Intracranial High-Grade Gliomas Injected with Genetically Modified Herpes Simplex Virus.
J. D. Bradley, Y. Kataoka, S. Advani, S. M. Chung, R. B. Arani, G. Y. Gillespie, R. J. Whitley, J. M. Markert, B. Roizman, and R. R. Weichselbaum (1999)
Clin. Cancer Res. 5, 1517-1522
   Abstract »    Full Text »    PDF »
Vesicular Stomatitis Virus G Pseudotyped Retrovector Mediates Effective in Vivo Suicide Gene Delivery in Experimental Brain Cancer.
J. Galipeau, H. Li, A. Paquin, F. Sicilia, G. Karpati, and J. Nalbantoglu (1999)
Cancer Res. 59, 2384-2394
   Abstract »    Full Text »    PDF »
Current Therapy for Brain Tumors: Back to the Future.
W. R. Shapiro (1999)
Arch Neurol 56, 429-432
   Abstract »    Full Text »    PDF »
New Molecular Strategies to Cure Brain Tumors.
H. Fathallah-Shaykh (1999)
Arch Neurol 56, 449-453
   Abstract »    Full Text »    PDF »
Comparison of Activation of CPT-11 by Rabbit and Human Carboxylesterases for Use in Enzyme/Prodrug Therapy.
M. K. Danks, C. L. Morton, E. J. Krull, P. J. Cheshire, L. B. Richmond, C. W. Naeve, C. A. Pawlik, P. J. Houghton, and P. M. Potter (1999)
Clin. Cancer Res. 5, 917-924
   Abstract »    Full Text »    PDF »
Cancer gene therapy update.
J. A Smith and B. R Goldspiel (1999)
Journal of Oncology Pharmacy Practice 5, 7-21
   Abstract »    PDF »
Eradication of Rat Malignant Gliomas by Retroviral-mediated, in Vivo Delivery of the Interleukin 4 Gene.
S. Benedetti, M. G. Bruzzone, B. Pollo, F. DiMeco, L. Magrassi, B. Pirola, N. Cirenei, M. P. Colombo, and G. Finocchiaro (1999)
Cancer Res. 59, 645-652
   Abstract »    Full Text »    PDF »
Cytotoxicity and Accumulation of Ganciclovir Triphosphate in Bystander Cells Cocultured with Herpes Simplex Virus Type 1 Thymidine Kinase-expressing Human Glioblastoma Cells.
L. Z. Rubsam, P. D. Boucher, P. J. Murphy, M. KuKuruga, and D. S. Shewach (1999)
Cancer Res. 59, 669-675
   Abstract »    Full Text »    PDF »
Therapy of Colon Cancer with Oncolytic Adenovirus Is Enhanced by the Addition of Herpes Simplex Virus-thymidine kinase.
O. Wildner, R. M. Blaese, and J. C. Morris (1999)
Cancer Res. 59, 410-413
   Abstract »    Full Text »    PDF »
Interferon-beta gene therapy inhibits tumor formation and causes regression of established tumors in immune-deficient mice.
X.-Q. Qin, N. Tao, A. Dergay, P. Moy, S. Fawell, A. Davis, J. M. Wilson, and J. Barsoum (1998)
PNAS 95, 14411-14416
   Abstract »    Full Text »    PDF »
Combination Gene Delivery of the Cell Cycle Inhibitor p27 with Thymidine Kinase Enhances Prodrug Cytotoxicity.
X. Danthinne, K. Aoki, A. L. Kurachi, G. J. Nabel, and E. G. Nabel (1998)
J. Virol. 72, 9201-9207
   Abstract »    Full Text »    PDF »
Synthetic activation of caspases: Artificial death switches.
R. A. MacCorkle, K. W. Freeman, and D. M. Spencer (1998)
PNAS 95, 3655-3660
   Abstract »    Full Text »    PDF »
Bystander Tumoricidal Effect and Gap Junctional Communication in Lung Cancer Cell Lines.
K. Imaizumi, Y. Hasegawa, T. Kawabe, N. Emi, H. Saito, K. Naruse, and K. Shimokata (1998)
Am. J. Respir. Cell Mol. Biol. 18, 205-212
   Abstract »    Full Text »
Gene Therapy for Infectious Diseases.
B. A. Bunnell and R. A. Morgan (1998)
Clin. Microbiol. Rev. 11, 42-56
   Abstract »    Full Text »    PDF »
Tissue-specific expression of herpes simplex virus thymidine kinase gene delivered by adeno-associated virus inhibits the growth of human hepatocellular carcinoma in athymic mice.
H. Su, R. Lu, J. C. Chang, and Y. W. Kan (1997)
PNAS 94, 13891-13896
   Abstract »    Full Text »    PDF »
Apoptosis in neural development and disease.
N. D Mazarakis, A D. Edwards, and H. Mehmet (1997)
Arch. Dis. Child. Fetal Neonatal Ed. 77, 165F-170
   Full Text »
A 2.7-kb Portion of the 5' Flanking Region of the Murine Glycoprotein alpha IIb Gene Is Transcriptionally Active in Primitive Hematopoietic Progenitor Cells.
P. Tropel, V. Roullot, M. Vernet, C. Poujol, H. Pointu, P. Nurden, G. Marguerie, and D. Tronik-Le Roux (1997)
Blood 90, 2995-3004
   Abstract »    Full Text »    PDF »
Liposome mediated gene transfer into the rat oesophagus.
R M Schmid, H Weidenbach, G F Draenert, S Liptay, H Luhrs, and G Adler (1997)
Gut 41, 549-556
   Abstract »    Full Text »    PDF »
Reduction of Restenosis After Angioplasty in an Atheromatous Rabbit Model by Suicide Gene Therapy.
P. G. Steg, O. Tahlil, N. Aubailly, J.-M. Caillaud, J.-F. Dedieu, K. Berthelot, A. Le Roux, L. Feldman, M. Perricaudet, P. Denefle, et al. (1997)
Circulation 96, 408-411
   Abstract »    Full Text »
Amphotropic murine leukemia viruses induce spongiform encephalomyelopathy.
C. Munk, J. Lohler, V. Prassolov, U. Just, M. Stockschlader, and C. Stocking (1997)
PNAS 94, 5837-5842
   Abstract »    Full Text »    PDF »
Gene Transfer to Cerebral Blood Vessels After Subarachnoid Hemorrhage.
M. G. Muhonen, H. Ooboshi, M. J. Welsh, B. L. Davidson, and D. D. Heistad (1997)
Stroke 28, 822-829
   Abstract »    Full Text »
Topical Review: Gene Therapy for Neurologic Disease: Benchtop Discoveries to Bedside Applications. 1. The Bench.
B. L. Maria, C. D. Medina, K. B.N. Hoang, and M. I. Phillips (1997)
J Child Neurol 12, 1-12
   Abstract »    PDF »
Graded Sonic Hedgehog Signaling and the Specification of Cell Fate in the Ventral Neural Tube.
J. Ericson, J. Briscoe, P. Rashbass, V. van Heyningen, and T.M. Jessell (1997)
Cold Spring Harb Symp Quant Biol 62, 451-466
   Abstract »    PDF »
A Novel Herpes Vector for the High-Efficiency Transduction of Normal and Malignant Human Hematopoietic Cells.
D. Dilloo, D. Rill, C. Entwistle, M. Boursnell, W. Zhong, W. Holden, M. Holladay, S. Inglis, and M. Brenner (1997)
Blood 89, 119-127
   Abstract »    Full Text »    PDF »
Conditional Ablation of Cerebellar Astrocytes in Postnatal Transgenic Mice.
C. L. Delaney, M. Brenner, and A. Messing (1996)
J. Neurosci. 16, 6908-6918
   Abstract »    Full Text »    PDF »
HSV-tk Gene Therapy in Head and Neck Squamous Cell Carcinoma: Enhancement by the Local and Distant Bystander Effect.
K. M. Wilson, P. J. Stambrook, W. L. Bi, Z. P. Pavelic, L. Pavelic, and J. L. Gluckman (1996)
Arch Otolaryngol Head Neck Surg 122, 746-749
   Abstract »    PDF »
Gene therapy for vascular smooth muscle cell proliferation after arterial injury.
T Ohno, D Gordon, H San, V. Pompili, M. Imperiale, G. Nabel, and E. Nabel (1994)
Science 265, 781-784
   Abstract »    PDF »
Neurological Surgery.
R. H. Wilkins (1994)
JAMA 271, 1684-1685
   Abstract »    PDF »
Current Issues in Cancer: Genes dreams and cancer.
K Sikora (1994)
BMJ 308, 1217-1221
   Full Text »
Toxicity and Immunologic Effects of In Vivo Retrovirus-mediated Gene Transfer of the Herpes Simplex-Thymidine Kinase Gene into Solid Tumors.
K.W. Culver, D.W. Moorman, R.R. Muldoon, R.M. Paulsen Jr., J.L. Lamsam, H.W. Walling, and C.J. Link Jr. (1994)
Cold Spring Harb Symp Quant Biol 59, 685-690
   Abstract »    PDF »
Gene Therapy for Neurologic Disease.
S. T. Suhr and F. H. Gage (1993)
Arch Neurol 50, 1252-1268
   Abstract »    PDF »
Gene Therapy.
F. Levine and T. Friedmann (1993)
Arch Pediatr Adolesc Med 147, 1167-1174
   Abstract »    PDF »
Regulation of Somatic-Cell Therapy and Gene Therapy by the Food and Drug Administration.
D. A. Kessler, J. P. Siegel, P. D. Noguchi, K. C. Zoon, K. L. Feiden, and J. Woodcock (1993)
N. Engl. J. Med. 329, 1169-1173
   Full Text »
The basic science of gene therapy.
R. Mulligan (1993)
Science 260, 926-932
   Abstract »    PDF »
Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA.
J Trojan, T. Johnson, S. Rudin, J Ilan, M. Tykocinski, and J Ilan (1993)
Science 259, 94-97
   Abstract »    PDF »
Brain tumor treatment: significant contributions.
R. Blaese, K. Culver, H Ishii, E. Oldfield, Z Ram, and S Wallbridge (1992)
Science 258, 1960
   PDF »
GENE THERAPY FOR BRAIN CANCER.
(1992)
Journal Watch (General) 1992, 5
   Full Text »
Retroviral Transduction of Cancer Cell Lines with the Gene Encoding Drosophila melanogaster Multisubstrate Deoxyribonucleoside Kinase.
X. Zheng, M. Johansson, and A. Karlsson (2000)
J. Biol. Chem. 275, 39125-39129
   Abstract »    Full Text »    PDF »
The Rational of Catalytic Activity of Herpes Simplex Virus Thymidine Kinase. A COMBINED BIOCHEMICAL AND QUANTUM CHEMICAL STUDY.
M. Sulpizi, P. Schelling, G. Folkers, P. Carloni, and L. Scapozza (2001)
J. Biol. Chem. 276, 21692-21697
   Abstract »    Full Text »    PDF »
Noninvasive gene targeting to the brain.
N. Shi and W. M. Pardridge (2000)
PNAS 97, 7567-7572
   Abstract »    Full Text »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)